Understand The Pros and Cons of Lemtrada RRMS Treatments

Lemtrada Stroke Lawsuit News

Lemtrada is an essential therapy for people who suffer from the most advanced and untreatable stages of relapse-remitting multiple sclerosis

Wednesday, October 16, 2019 - Doctors and patients must understand the benefits and extreme side effects that the drug carries, including causing death. Sanofi, the maker of Lemtrada, has gone to great lengths to educate doctors and patients with RRMS about the facts about the drug. In the end, only the patient can decide if Lemtrada is right for them. If you are considering starting to take Lemtrada, please go to www.Lemtrada.com and read the web site thoroughly. I have done so and below are some of the highlights I think are very important to know.

Sanofi stresses five main points as the basis for understanding Lemtrada (alemtuzumab). The first item to consider is that Lemtrada (alemtuzumab) is for adults only and is a drug of last resort only to be taken when at least two others have failed to control your RRMS symptoms. The second important point is that Lemtrada is administered to RRMS patients in a procedure that you may not have experienced previously. According to Sanofi, Lemtrada "is administered in 8 doses over two years-on 5 consecutive days in round 1 and, one year later, on 3 consecutive days in round 2." Lemtrada lawsuit attorneys representing people and families nationwide, offer a free consultation before filing a claim.

Before starting to receive Lemtrada a patient and their doctor must first sign up and complete the Lemtrada Risk Evaluation and Mitigation Strategy (REMS) program so that everyone knows the risks that include having a paralyzing stroke and sudden death from a heart attack. Doctors will need to check on a Lemtrada patient regularly and to watch for the symptoms that something may be wrong. "(Lemtrada patients) will be monitored monthly starting after the first infusion and continue to monitor until 4 years or longer after the last round of treatment."

The fourth point to consider once the risks have been digested is more positive and encouraging in that 65% of Lemtrada patients "were relapse-free" after 2 years. In an extended study, "79-87% of RRMS patients were relapse-free from 3-6 years." Finally, if you and your doctor agree that Lemtrada is the right treatment for you, Sanofi makes a package of financial assistance available to you.

It is critical that both the doctor and patient know the early warning signs of Lemtrada's potentially deadly side effects in advance and diligently watch for them both during and after treatments. Lemtrada causes kidney problems which can lead to kidney damage and failure requiring dialysis and eventually a kidney transplant. Watch for "swelling of your legs or feet; blood in the urine (red or tea-colored urine); decrease in urine; fatigue; coughing up blood," according to Sanofi. Lemtrada also causes blood clotting problems called "Immune thrombocytopenic purpura (ITP), a condition of reduced platelet counts in your blood that can cause severe bleeding that may cause life-threatening problems." Symptoms of ITP are "easy bruising; bleeding from a cut that is hard to stop; coughing up blood; heavier menstrual periods than normal; bleeding from your gums or nose that is new or takes longer than usual to stop; small, scattered spots on your skin that are red, pink, or purple."

More Recent Lemtrada Stroke Lawsuit News:

No-Cost, No-Obligation Lemtrada Lawsuit Case Review If You or a Loved One Suffered from Lemtrada Stroke Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.